key: cord-0913669-h5nenrkk
authors: Kumar, Nitish; Singh, Atamjit; Gulati, Harmandeep Kaur; Bhagat, Kavita; Kaur, Komalpreet; Kaur, Jaspreet; dudhal, Shilpa; Duggal, Amit; Gulati, Puja; Singh, Harbinder; Singh, Jatinder Vir; Bedi, Preet Mohinder Singh
title: Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: in silico study
date: 2021-06-06
journal: Phytomedicine Plus : International journal of phytotherapy and phytopharmacology
DOI: 10.1016/j.phyplu.2021.100083
sha: dde57458f89c4c8f1310018839ef45f417d919fc
doc_id: 913669
cord_uid: h5nenrkk

Background Lack of treatment of novel Coronavirus disease led to the search of specific antivirals that are capable to inhibit the replication of the virus. The plant kingdom has demonstrated to be an important source of new molecules with antiviral potential. Purpose The present study aims to utilize various computational tools to identify the most eligible drug candidate that have capabilities to halt the replication of SARS-COV-2 virus by inhibiting Main protease (Mpro) enzyme Methods We have selected plants whose extracts have inhibitory potential against previously discovered coronaviruses. Their phytoconstituents were surveyed and a library of 100 molecules was prepared. Then, computational tools such as molecular docking, ADMET and molecular dynamic simulations were utilized to screen the compounds and evaluate them against Mpro enzyme. Results All the phytoconstituents showed good binding affinities towards Mpro enzyme. Among them laurolitsine possesses the highest binding affinity i.e. -294.1533 kcal/mol. On ADMET analysis of best three ligands were simulated for 1.2 ns, then the stable ligand among them was further simulated for 20 ns. Results revealed that no conformational changes were observed in the laurolitsine w.r.t. protein residues and low RMSD value suggested that the Laurolitsine-protein complex was stable for 20ns. Conclusion Laurolitsine, an active constituent of roots of Lindera aggregata, was found to be having good ADMET profile and have capabilities to halt the activity of the enzyme. Therefore, this makes laurolitsine a good drug candidate for the treatment of COVID-19.

We have selected plants whose extracts have inhibitory potential against previously discovered coronaviruses. Their phytoconstituents were surveyed and a library of 100 molecules was prepared. Then, computational tools such as molecular docking, ADMET and molecular dynamic simulations were utilized to screen the compounds and evaluate them against Mpro enzyme.

All the phytoconstituents showed good binding affinities towards Mpro enzyme. Among them laurolitsine possesses the highest binding affinity i.e. -294.1533 kcal/mol. On ADMET analysis of best three ligands were simulated for 1.2 ns, then the stable ligand among them was further simulated for 20 ns. Results revealed that no conformational changes were observed in the laurolitsine w.r.t. protein residues and low RMSD value suggested that the Laurolitsine-protein complex was stable for 20ns.

Laurolitsine, an active constituent of roots of Lindera aggregata, was found to be having good ADMET profile and have capabilities to halt the activity of the enzyme. Therefore, this makes laurolitsine a good drug candidate for the treatment of COVID-19.

Natural Antiviral herbs, Covid-19, M pro protein, Molecular Dynamic Simulations, ADMET. Abbreviations α, alpha; Å, angstrom; ACE-2, Angiotensin converting enzyme-2; ADMET, absorption, Distribution, metabolism, excretion and toxicity; Ala, Alanine; Approx., approximately; Arg, arginine; Asn, Asparagine; Asp, Aspartic acid; β, beta; CADD, Computer Aided Drug Design;

CHARMM, Chemistry at Harvard Macromolecular Mechanics; COVID, Novel corona-virus

Novel coronavirus disease (COVID) broke out in late 2019 in Wuhan city (China), from where, it spread to other parts of the world . On Mar 11 th , 2020, the World Health Organization declared the COVID-19 as a pandemic and till Jan 7 th , 2021, the virus had already infected approx. 85.1 million people and caused 1.8 million deaths across the globe. Countries such as USA, Brazil and India have been severely affected by this pandemic (Cucinotta and Vanelli, 2020; WHO, 2020) although at present other countries are suffering new outbreaks.

Common symptoms of this disease include fever, cough, shortness of breath, loss of taste and pneumonia; whereas severe conditions include respiratory, gastrointestinal, hepatic and neurological complications among others (Pan et al., 2020; Singhal, 2020) . After exposure, it generally takes 2-14 days to develop mild or severe symptoms. Direct contact with the infected person or respiratory droplets are considered as major modes of transmission (Huang et al., 2020) . COVID was caused by Novel Coronavirus 2019 (nCOV-19) or severe acute respiratory syndrome coronavirus-2 (SAR-COV-2) which belongs to beta coronavirus (COV) category of Coronaviridae family (Chen et al., 2020; Kanhed et al., 2020) . This virus was thought to be sourced from bats (major reservoirs of α-COV and β-COV) but their transmission pattern has not been elucidated yet (Cui et al., 2019) . nCOV-19 has a bi-lipid layer envelope that protects and stores genetic material i.e. RNA and N protein, Moreover, envelope surface has other proteins such as spike glycoprotein, membrane protein, envelope protein and hemagglutinin/esterase that help the virus to invade the host cell and perform other replication related tasks (Figure 1 ).

Among them spike glycoprotein guides nCOV-19 to invade host cell by binding to the host's ACE-2 receptor ( Figure 2 ) with 1000 times more binding affinity than ACE-2 inhibitors discovered till now (He et al., 2020) . After binding, the virus utilizes the receptor and enters the cytosol of the host cell where it un-coats and releases genetic material comprising of 30,000 nucleotides. Later, the genetic material gets translated by ribosomes to synthesize polyproteins.

Maturation of these synthesized polyproteins is carried out by main protease enzyme (M pro ) which performs autolytic cleavage at not less than 11 conserved sites. These mature proteins merge again to generate a new viral envelope and accessory proteins that results in the formation of a new copy of virus (Mathewson et al., 2008) . Therefore, suggesting two methods to halt the replication of virus. Firstly, by preventing the invasion of virus into the host cell by blocking ACE-2 receptor, and secondly, by inhibiting the activity of M pro to pause the replication of virus. Furthermore, a study has reported that normal levels of ACE-2 receptors are required to combat the inflammatory response in the lungs.

Angiotensin-II (an activator of Angiotensin-II type-1 receptor which on activation leads to acute lung injury) is degraded by ACE-2 receptor ( Figure 3 ). In case of nCOV-19 infection, ACE-2 receptors are occupied by the virus for its invasion into the host cell which indirectly increases the Angiotensin-II levels (Shenoy et al., 2011) . This increase leads to activation of Angiotensin-II type-1 receptor causing vasoconstriction, proliferation and inflammation of the tissue leading to acute cell injury (Kai and Kai, 2020) . Pulmonary arteries and veins have ACE-2 receptors whose blockage can cause constriction of arteries and veins, which can worsen the condition of the patient or may lead to lung failure also (Guignabert et al., 2018; Jia, 2016; Shenoy et al., 2011) . On the other hand, the inhibition of M pro is crucial for preventing the maturation of polyproteins that ultimately stops the spread of virus to other healthy cells. Moreover, the absence of closely related homologues of M pro in humans also makes it a safe and potential target for the development of antivirals (Hall and Ji, 2020) .

Currently, several M pro inhibitors are proposed by researchers across the globe as potential drug targets for the treatment of coronavirus disease but they still lack optimum specificity and efficacy towards this protein. The conventional development of a new drug or vaccine requires a huge investment of money and time. From the last few years, computer-aided drug design (CADD) has played a prominent role in the development of numerous clinical drug candidates including Dorzolamide, Saquinavir and Aliskiren (Talele et al., 2010) . Moreover, CADD provides more efficient and much cheaper and alternative path to design and develop bioactive molecules with high specificity and efficacy (Surabhi and Singh, 2018) . In addition, various tools of CADD such as virtual screening, molecular docking, molecular dynamic simulations etc. are very effective in predicting the potential leads or drug candidates for various diseases. On the other hand, medicinal plants have successfully delivered a wide range of drug candidates to clinical practice. Thus, screening of phytoconstituents from antiviral medicinal plants using CADD is an efficient approach to identify potential leads against nCOV-19. Therefore, during literature survey, we came across ten natural herbs whose phytoconstituents or extracts were found to be beneficial in the treatment of previously discovered coronaviruses (Lin et al., 2014) . (Taxaceae) were found to inhibit nsP13 helicase and 3CL protease of SARS-COV (Lin et al., 2005; Ryu et al., 2010; Yu et al., 2012) . Water extract from Houttuynia cordata Thunb.

(Saururaceae) was also found to inhibit viral 3CL protease and RNA dependent RNA polymerase (Lau et al., 2008) . As the extracts of these plants possess antiviral properties.

Therefore, their phytoconstituents were chosen and screened against the M pro using various in silico techniques in order to precisely identify the drug candidate for the treatment of COVID-19.

A schematic workflow was followed to perform various in silico studies as shown in Figure 4 .

Molecular docking studies were carried out using DS Biovia's Discovery studio (DSBDS) software with hardware configuration of Intel(R) Core (TM) i7-3612QM CPU @ 2.10 GHz with 12 GB of RAM running on windows 10 x64 bit operating system. Further, Molecular Dynamics Simulations were performed using DE Shaw's Desmond software with the hardware configuration of Intel(R) Pentium Dual-core E5400 CPU @ 2.70 GHz with Nvidia Geforce GT 710 and 4 GB of RAM running on Ubuntu 18.04 x64 bit operating system.

As discussed above, ten natural herbs whose phytoconstituents or extracts were found to be beneficial in the treatment of previously discovered coronaviruses were chosen. Structures of their phytoconstituents were surveyed and downloaded from the PubChem database in structure data format (SDF) format (complete details of Phytoconstituents mentioned in supplementary excel sheet no. S1). These SDF files were then prepared using -prepare ligands‖ module and filtered using -Filter by Lipinski and Veber's Rules‖ module of DSBDS software. This process removed duplicate entries, computed isomers and tautomer, and generated 3D conformations and minimized them (Dassault Systèmes BIOVIA, 2020).

3D structure of M pro (PDB code: 5RE4) in complex with N-(4-methylpyridin-3-yl)acetamide inhibitor (NI) was downloaded from RCSB Protein Data Bank. The PDB file of M pro was prepared using -prepare protein‖ module of DSBDS software. This process cleaned the PDB file, optimized the side-chains conformation for residues, removed water molecules, remodelled missing loop regions utilizing SEQRES information and protonated the structure at pH 7.4. Later the prepared PDB file was typed with CHARMM forcefield in order to score the docked poses and to calculate binding energies. In addition, the co-crystallized compound -NI‖ in 5RE4 PDB file which was used to detect the active binding site by generating binding sphere (Dassault Systèmes BIOVIA, 2020).

Prior to docking the prepared ligands, the co-crystallized ligand NI was removed from the active binding and then High throughput screening of prepared ligands w.r.t M pro was done using -LibDock‖ module of DSBDS. A total of 100 hotspots were setup with docking tolerance of 0.25 and a high-quality docking parameter. A Fast conformation method was chosen with a cut off value of 255 and minimization algorithm were set to -do not minimize‖ in order to rigidly dock the ligands on the active binding site of M pro . Parallel processing was utilized with a batch size of 25 in order to speed up the docking process (Dassault Systèmes BIOVIA, 2020)

After successful high throughput screening of ligands, an empirical fitting approach and knowledge-based statistical approach of -Score ligand poses‖ module of DSBDS was utilized.

This process scored the confirmations and helped to speed up the process of estimation of binding energies of ligands (Dassault Systèmes BIOVIA, 2020) . Later, these scored ligands were used by -Calculate binding energies‖ module of DSBDS to estimate the binding energy between the enzyme and the ligand Energy Binding = Energy Complex -Energy Ligand -Energy Receptor Prior to calculation of binding energy and conformation entropy "In situ ligand minimization" was turned on. This "In situ ligand minimization" utilizes smart minimizer to minimize each ligand up to 1000 steps with RMS gradient of 0.001 and removes any van der waals clashes of ligands. After minimization, binding energies were calculated which were used to prioritize the ligand poses (Dassault Systèmes BIOVIA, 2020).

All the ligands were screened using standard parameters of -ADMET descriptors‖ and -toxicity prediction (extensible)‖ modules of DSBDS for the calculation and estimation of various ADMET parameters (Dassault Systèmes BIOVIA, 2020; Han et al., 2019) .

In order to mimic the biological system, a system of protein and ligand complex was generated by using -system builder‖ module of DE Shaw Desmond software. A SPC solvent model was selected with orthorhombic box shape with 10x10x10 dimensions. Later, Counter ions (Na + or Cl -) for neutralization were added, system's concentration was set to 0.15 M and OPLS3e force field was applied to the system. Later, A short 1.2 ns MD simulation was performed between M pro (5RE4) and best 3 ligands by using -Molecular Dynamics‖ module of DE Shaw Desmond.

A 5-stage minimization of model system was performed prior to final MD simulation. These stages are : (a) stage 1 -simulates Brownian Dynamics NVT, T = 10 K, small timesteps, and restraints on solute heavy atoms, 100ps; (b) stage 2 -simulates NVT, T = 10 K, small timesteps, and restraints on solute heavy atoms, 12ps; (c) stage 3 -simulate NPT, T = 10 K, and restraints on solute heavy atoms, 12ps; (d) stage 4 -simulate, NPT and restraints on solute heavy atoms, 12ps; (d) stage 5 -simulate, NPT and no restraints, 24ps; (e) stage 6final simulation for 1.2 ns that covers about 200K steps. Result of these simulations were analyzed and the compound which showed minimum variations was then again evaluated by performing simulation for further 20 ns with same standard parameters (Bowers et al., 2006) .

The crystalline structure of M pro (resolution 1.88 Å) was prepared and minimized using‖ prepare protein‖ module and its analysis showed that there were no missing residues within the protein.

The Ramachandran plot showed no violation of amino acid's torsion angles and the energies of all the residues were within the low energy zones with glycine as an exception (Figure no. 5A) .

Hence, concluding that the protein has been minimized. Moreover, this 33.8 kDa protein consists of 304 amino acids and has 3 domains ranging from (a) 8-101 (red), (b) 102-184 (green) and (c) 201-303 (blue). The main catalytic site (grey colored) with 63 amino acids is present in a cleft between the first and second domain ( Figure 5B ). His-41, Cys-145 and His-164 residues are the crucial amino acids involved in the catalytic activity and these must be blocked to halt the activity of the M pro . Therefore, these amino acids involved in catalytic activity of enzyme and native ligand NI were selected to generate a binding sphere at x: 8.660620, y: -1.671627, z: 24.136016 coordinates with a radius of 7.30 Å, this was done to give coordinates of active binding site to the software to perform docking.

Before performing high throughput screening of selected antiviral ligands, validation of docking protocol was done by re-docking co-crystalized ligand NI with M pro . The docking results revealed that the interaction pattern of re-docked NI inhibitor was same as that in the crystallized state i.e., interacting with Glu-166, Cys-145 and Asn-142 amino acid residues with a RMSD value of 0.31659 and binding energy of -123.024 Kcal/mol ( Figure 5C ).

After validation of the parameters, the prepared library which contains 30% of alkaloid, 21% terpenes, 14% of glycosides, 8 % each of terpenoids and saponins, 7% of flavonoids, 4% of phenolic and remaining 8% comprises of alcohols, phytosterols, flavone, alkane and other organic compounds was screened using -Lipinski's and Veber's rule of five". This ruled out 30 molecules from the library as they were violating the parameters and then high throughput screening of remaining ligands were performed with the same validated parameters. This rigid docking of the ligands generated approx. 15,327 conformations which were then scored and sorted according to their dock score and binding energies values.

On analyzing the docking results, most of the molecules were found to be interacting with the amino acids involved in catalytic activity i.e. His-41, Cys-145 and His-164 ( Figure 6A ). The hydrophobic interaction of Cys-145 residue was found to be the most favorable, but also showed fewer hydrogen bonding interactions with the molecules. Whereas, other residues participating in hydrophobic interaction are . Other residues such as Table 1 .

The values signify that the molecules have capabilities to block the active site with good binding affinities. Among the top 10, laurolitsine showed the highest binding affinity i.e. -294.1533 kcal/mol which was approx. 2 times more than NI (-123.024 Kcal/mol) and considerably higher than N3 inhibitor (-262.071 Kcal/mol).

Moreover, it was observed that among top 10 molecules, 8 molecules were alkaloid derivatives and one bioflavonoid and one phenolic compound which signifies that structure of alkaloids derivatives have the desired pharmacophoric features to perfectly bind and halt the activity of the enzyme. The 2D interaction diagrams of top 10 molecules that are laurolitsine (aporphine alkaloid), laurotetanine (isoquinoline alkaloid), ginkgetin (biflavonoid), norisoboldine (isoquinoline alkaloid), isoboldine (isoquinoline alkaloid), secoboldine (phenanthrene alkaloids), boldine (aporphine alkaloids), pseudolycorine (alkaloid), syringic acid (phenolic derivative), lauroscholtzine (isoquinoline alkaloid) are shown in Figure 6B which suggest that the molecules were interacting with all major amino acids involved in the catalytic activity of the M pro .

Further, the drug-likeliness of top ten molecules was evaluated through Lipinski's rule of five parameters and the values are summarised in Table 1 (values of all the molecules are mentioned in supplementary excel sheet no. S3). It was found that parameters of all molecules were within standard ranges except ginkgetin, which was found to be violating all the parameters. The molecular weight of molecules (except ginkgetin) was less than 500, log p was lower than 5.0 which suggest that molecules were not very lipophilic and their molar refractivity index was in the range of 98.4-111.85 which was within the limits of accepted value of 40-130 (Lipinski, 2004) .

Further, the physicochemical and structural properties of all the docked molecules were utilized to check the mutagenicity and ADMET parameters. These parameters were evaluated by -ADMET descriptors‖ and -toxicity prediction (extensible)‖ modules of DSBDS (Han et al., 2019; Reddy et al., 2012) . Ponnan et al., (2013) specified a set of rules (supplementary excel sheet no. S2) that were utilized to specify the threshold values of parameters. The values of predicted parameters of top 10 molecules were summarised in Table 2 , which showed that all compounds except ginkgetin had good intestinal absorption capacity and good aqueous solubility. None of the compound was found to inhibit cytochrome P450 2D6 enzyme. Whereas secoboldine and lauroscholtzine were found to have mutagenic nature, and all the compounds were found to be hepatotoxic. Moreover, the plot ( Results of MD were analyzed and on aligning ligand RMSD with respect to (w.r.t.) protein's backbone RMSD revealed that the variations of top 3 ligands were reported to be less than 3 Å ( Figure 8i) . Moreover, ligand RMSD of laurolitsine showed very low deviation as compared to RMSD's of laurotetanine and ginkgetin. For laurolitsine, RMSD varied near to the value of 0.20 for the first 200 ps, but later varied between a range of 0.40 to 0.60 till 1200 ps. A slight increase was observed but was within the 3 Å margin, hence suggesting that the protein-ligand complex was stable for 1.2 ns without showing any major orientational changes.

Furthermore, the local changes within the protein residues were understood by calculating protein's root mean square fluctuations (RMSF) where green colored vertical lines in the graph shows contact of ligand's atoms with amino acid residues of protein ( Figure 8ii ). The results revealed that protein's backbone showed no significant fluctuations w.r.t. these compounds.

RMSF of backbone w.r.t laurolitsine was between 0.4 Å and 1.6 Å, but the fluctuation was minimal where the amino acid residues were in contact with laurolitsine atoms. Moreover, RMSF of laurotetanine and ginkgetin shared the same pattern of fluctuation. Thus, it can be concluded that there were no major fluctuations in the backbone of the protein w.r.t. ligands.

Later, interaction patterns for these ligands were studied w.r.t. time ( Figure 8iv ) and it was observed that the interactions circulated within the residues Thr-26, and Gln-189 throughout the simulation. At a time, a maximum of 9 residues were observed to be in contact with the ligand. In the case of laurolitsine and laurotetanine, the interaction with Glu-166 was observed to be consistent throughout the timeline but was inconsistent in the case of ginkgetin. Moving towards the interaction fraction of ligands with protein residues (Figure 8iii ), most interactions in case of laurolitsine were through hydrogen bonding and water bridges; but showed few hydrophobic and ionic interactions. Whereas, in case of laurotetanine and ginkgetin, water bridges were more prominently observed than other interactions. This concludes that laurolitsine has more tendency to interact with the residues of the M pro directly as compared to laurotetanine and ginkgetin.

Apart from above observations, solvent accessible surface area analysis, Radius of gyration (rGyr), Molecular Surface Area (MoISA) and Polar Surface Area (PSA) further supported the stability of protein-ligand complex (Figure 8v) . But, ginkgetin showed quite significant fluctuations in intramolecular hydrogen bonding which may be due to its flexibility.

The three compounds were found to be stable but laurolitsine showed least variations therefore the stability of M pro -laurolitsine complex was further analyzed at 20 ns. The same previously used parameters were employed for MD simulation and initially docked pose was considered as a reference. On aligning the RMSDs of laurolitsine with M pro protein, the RMSD variation pattern was observed to be the same as was in initial 1.2 ns MD simulations, after 10 ns the variation lowered to 0.4 (approx.) which suggested that the system has further moved toward equilibrium which further support the stability of protein-ligand complex ( Figure 9A ). On the other hand, RMSF of protein was more fluctuating as compared to 1.2 ns simulation which was smoother ( Figure 9B ). But the fluctuations observed were within the range of 0.5 and 2.0 Å that is an acceptable range. Loss of a few contact points with the ligand was observed. In conclusion, these RMSD and RMSF patterns confirmed stability of the laurolitsine and M pro complex.

The interaction timelines of laurolitsine and M pro residues w.r.t. time revealed that the interactions of laurolitsine with Glu-166 (contacts between 3 or 4) and Asn-142 (contacts between 1 or 2) residues were stable and observed to be consistent throughout the simulation ( Figure 9C ). Other residues interacting with laurolitsine were . Histogram plot of interaction fractions showed that laurolitsine was mainly interacting via water bridges and H-bonds but have fewer hydrophobic and ionic interactions with the M pro ( Figure 9D and 9F) . Other statistical parameters, such as SASA analysis, rGyr, MoISA and PSA were within the acceptable ranges that added their support for stability of M pro -ligand complex.

All the phytoconstituents interacted well with M pro protein and possesses good binding affinities but alkaloid-class derivatives were found to be dominating than the others. Among them, laurolitsine was the most promising compound with highest binding energy and its complex with M pro was found to be stable for 20 ns. In addition to this, laurotetanine and ginkgetin were also among the top 3 drug candidates as they also have good binding affinity towards M pro protein with good ADMET profile but their complex with M pro showed much more variations than the laurolitsine-M pro complex. Apart from this laurolitsine also possesses a good ADMET profile and it is an active constituent derived from roots of Lindera aggregata whose extract has already proven for its anti-SARS-COV effect. All these properties make laurolitsine a promising candidate for the treatment of COVID-19. 

Scalable algorithms for molecular dynamics simulations on commodity clusters

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Antiviral effects of saikosaponins on human coronavirus 229E in vitro

WHO declares COVID-19 a pandemic

Origin and evolution of pathogenic coronaviruses

Discovery Studio Modeling Environment

ACE2 as therapy for pulmonary arterial hypertension: The good outweighs the bad

A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease

In silico ADME and toxicity prediction of ceftazidime and its impurities

Coronavirus disease 2019: What we know?

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19

Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach

Immunomodulatory and anti-SARS activities of Houttuynia cordata

Identification of natural compounds with antiviral activities against SARS-associated coronavirus

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

Antiviral natural products and herbal medicines

Lead-and drug-like compounds: The rule-of-five revolution

Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study

2D-QSAR, docking studies, and in silico ADMET prediction of polyphenolic acetates as substrates for protein acetyltransferase function of glutamine synthetase of mycobacterium tuberculosis

ADMET, docking studies & binding energy calculations of some novel ACE -Inhibitors for the treatment of diabetic nephropathy

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition

ACE2, a promising therapeutic target for pulmonary hypertension

A Review of Coronavirus Disease-2019 (COVID-19)

Computer Aided Drug Design: an Overview

Successful applications of computer aided drug discovery: moving drugs from concept to the clinic

A novel coronavirus outbreak of global health concern

Brazil: WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard [WWW Document

Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13